These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 7962297

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M, Flamigni C, Meriggiola MC, Ferrari P, Michelacci L, Campaniello E, Valdiserri A, Cognigni G.
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [Abstract] [Full Text] [Related]

  • 3. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S, Taylor AE, Martin KA, Welt CK, Adams JM, Hall JE.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [Abstract] [Full Text] [Related]

  • 4. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M, Flamigni C, Campaniello E, Valdiserri A, Ferrari P, Meriggiola MC, Michelacci L, Pareschi A.
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [Abstract] [Full Text] [Related]

  • 5. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
    Martin KA, Hall JE, Adams JM, Crowley WF.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
    [Abstract] [Full Text] [Related]

  • 6. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis.
    Tranoulis A, Laios A, Pampanos A, Yannoukakos D, Loutradis D, Michala L.
    Fertil Steril; 2018 Apr; 109(4):708-719.e8. PubMed ID: 29605411
    [Abstract] [Full Text] [Related]

  • 9. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
    Tan SL, Farhi J, Homburg R, Jacobs HS.
    Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506
    [Abstract] [Full Text] [Related]

  • 10. Induction of ovulation with pulsatile gonadotropin releasing hormone (GnRH) in anovulatory women.
    Cignitti M, Mazzarini A, Pini A, Garzetti GG, Romanini C.
    Acta Eur Fertil; 1990 Aug; 21(5):235-8. PubMed ID: 2132474
    [Abstract] [Full Text] [Related]

  • 11. Increased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation induction.
    Filicori M, Flamigni C, Cognigni G, Dellai P, Michelacci L, Arnone R.
    Fertil Steril; 1994 Aug; 62(2):279-85. PubMed ID: 8034073
    [Abstract] [Full Text] [Related]

  • 12. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
    Filicori M, Flamigni C, Campaniello E, Meriggiola MC, Michelacci L, Valdiserri A, Ferrari P.
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.
    Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, Morris DV, Price J, Jacobs HS.
    Lancet; 1990 Nov; 2(8469-70):1375-9. PubMed ID: 2867389
    [Abstract] [Full Text] [Related]

  • 15. Pulsatile GnRH therapy for the induction of ovulation in hypogonadotropic hypogonadism.
    Blunt SM, Butt WR.
    Acta Endocrinol Suppl (Copenh); 1988 Nov; 288():58-65. PubMed ID: 3138867
    [Abstract] [Full Text] [Related]

  • 16. [Results of LHRH-A pretreatment in ovulation induction, using pulsatile administration of GnRH, in patients with polycystic ovaries].
    D'Amato G, Vizziello G, Fanizza G.
    Minerva Ginecol; 1992 May; 44(5):257-62. PubMed ID: 1608524
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of anovulation in hyperprolactinemic amenorrhea determined by pulsatile gonadotropin-releasing hormone injection combined with human chorionic gonadotropin.
    Matsuzaki T, Azuma K, Irahara M, Yasui T, Aono T.
    Fertil Steril; 1994 Dec; 62(6):1143-9. PubMed ID: 7957976
    [Abstract] [Full Text] [Related]

  • 18. Ovulation induction using s.c. pulsatile gonadotrophin-releasing hormone: effectiveness of different pulse frequencies.
    Letterie GS, Coddington CC, Collins RL, Merriam GR.
    Hum Reprod; 1996 Jan; 11(1):19-22. PubMed ID: 8671151
    [Abstract] [Full Text] [Related]

  • 19. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
    Ergür AR, Yergök YZ, Ertekin A, Küçük T, Müngen E, Tütüncü L.
    J Reprod Med; 1998 Mar; 43(3):185-90. PubMed ID: 9564642
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.